Heated Saline in Cervical Balloon for Labor Induction, a RCT

June 2, 2025 updated by: Begona Martinez de Tejada

Effect of Heated Saline in Duration of Cervical Ripening in Women Having Labor Induction With Cervical Balloon: a Randomized Controlled Study

This study is a single-center, randomized, two-arm, controlled trial, including women requiring cervical ripening during the process Induction of Labor using Balloon catheter (BC). The primary objective of the study is to determine if the use of heated saline in the BC used for cervical ripening reduces the length of BC duration.

Participants will be allocated to :

  • Intervention or warm group: the BC will be filled with heated saline water up to 40° C
  • Standard or room temperature group: the BC will be filled with saline water at room temperature.

Study Overview

Detailed Description

Background and Rationale:

Induction of Labor (IOL) is one of the most common interventions in obstetrics. IOL is performed due to fetal, maternal or pregnancy complications to reduce the risk of complication. IOL methods will depend of the state of the cervix at the beginning of the procedure. If cervix is considered unfavorable (Bishop score ≤ 5) an initial phase of ripening is usually proposed. There are various methods of cervical ripening, which can be divided into non-pharmacological (e.g., mechanical methods with transcervical Foley catheter or Cook balloon) and pharmacological (e.g., prostaglandins). IOL can be a long-lasting procedure, especially when cervical ripening is necessary.

Two recent, small studies have shown that the use of warm fluid to inflate the balloon catheter (BC) inserted through the cervix reduces the time of cervical ripening, hence potentially reducing the time of IOL. These results are the only data available regarding the use of saline at different temperatures for inflating the balloon in mechanical methods and show promising effects in terms of reduction in the length of the cervical ripening and labor.

The cervix is mainly composed of collagen. Studies show that the use of heat on connective tissue increase the potential elongation of collagen tissue and the denaturation of this protein.

We hypothesize that the use of heat in the cervical ripening can accelerate the denaturation of the collagen and accelerate the softening of the cervix and therefore reduce the duration of cervical ripening and labor.

Objective(s):

The primary objective of the study is to determine if the use of heated saline in the BC used for cervical ripening reduces the length of BC duration, defined as the time from the insertion to the expulsion or artificial removal of the BC.

The secondary objectives are to evaluate if the use of heated saline compared with room temperature:

  1. Decreases the length from the start of the induction until the achievement of a favorable cervix (Bishop score >5).
  2. Decreases the length from the start of the induction until full dilation
  3. Decreases the length from the start of the induction until delivery
  4. Increases the rate and the speed of spontaneous rupture of membranes (ROM) during cervical ripening
  5. Impacts on the rate of cesarean delivery.
  6. Impacts on the pain and the satisfaction in women undergoing cervical ripening
  7. Impacts on obstetrical and neonatal complications

Study Design:

Prospective, single-center, randomized, two-arm, controlled trial, including women requiring cervical ripening during the process IOL using Balloon catheter

Number of Participants with Rationale:

A total of 290 women will be recruited (145 women in each group) in order to show a reduction in the duration of BC placement, considering a significance criterion set to 0.05 (alpha, two- tailed), and an expected power of at least 90%.

Study procedures:

Patients will be allocated in one of this two groups:

  • Intervention or warm group: the BC will be filled with heated saline water up to 40° C
  • Standard or room temperature group: the BC will be filled with saline water at room temperature.

In both groups, the insertion of the BC will be done following the same procedure:

The operator will introduce a 14Fr or 18Fr Balloon catheter through the cervical canal, up above the internal orifice using a long Pean clamp and inflate the internal balloon with 30 to 80ml of saline water (NaCl 0.9%) -either heated or unheated, depending on the allocation group- according to the mechanic resistance with a graduated syringe.

Statistical Considerations Main analysis will be performed on an intention-to-treat basis. The main outcome will be evaluated by plotting survival functions according to the allocation group, using the Kaplan-Meier estimator. The associations will be considered as statistically significant when the p-value is below 0.05 (probability of type I error = 0.05). This analysis is also planned for objectives 2 (interval from beginning of IOL and achievement of a favorable cervix) and 3 (interval from beginning of IOL and delivery). For the other outcomes, comparison will be performed using Fisher's exact test, Student's t-test or the Mann-Whitney U test, according to the type of variable.

Study Type

Interventional

Enrollment (Actual)

290

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Genève
      • Geneva, Genève, Switzerland, 1205
        • Hôpitaux universitaires de Genève

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Gestational age at or over 35 weeks
  • Singleton pregnancy
  • Alive fetus
  • Cephalic presentation
  • Maternal age ≥ 16 years

Exclusion Criteria:

  • Active labor (dilated cervix with spontaneous uterine contractions)
  • Prelabor rupture of membranes
  • >1 Previous cesarean delivery
  • Fetal malformation leading to a possible obstruction of labor (e.g., hydrocephaly, exteriorized fetal tumors, etc.)
  • Maternal or fetal disease with indication to accelerate labor (start oxytocin stimulation within 6 hours after insertion of the BC (e.g., pre-eclampsia, chorioamnionitis, etc.)]
  • Counterindication to vaginal delivery
  • Impossibility to give consent to participation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Warm group
The Balloon Catheter will be filled with heated saline water up to 40° C
The operator will introduce a 14Fr or 18Fr Balloon catheter through the cervical canal, up above the internal orifice using a long Pean clamp and inflate the internal balloon with 30 to 80ml of Heated saline water (NaCl 0.9%) at 40°C - according to the mechanic resistance with a graduated syringe.
Active Comparator: Room temperature group
the Balloon Catheter will be filled with saline water at room temperature.
The operator will introduce a 14Fr or 18Fr Balloon catheter through the cervical canal, up above the internal orifice using a long Pean clamp and inflate the internal balloon with 30 to 80ml of unheated saline water (NaCl 0.9%) - according to the mechanic resistance with a graduated syringe.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To determine if the use of heated saline in the Balloon Catheter (BC), used for cervical ripening, reduces the length of BC duration, defined as the time from the insertion to spontaneous expulsion or artificial removal of the BC.
Time Frame: Through study completion, an average of 1.5 years
Duration of BC (i.e., positioning of the transcervical catheter): interval between insertion and retrieval, either after spontaneous expulsion or artificial retrieval.
Through study completion, an average of 1.5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
To evaluate if the use of heated saline compared with room temperature Decreases the length from the start of the induction until the achievement of a favorable cervix (Bishop score >5)
Time Frame: Through study completion, an average of 1.5 years
Length of cervical ripening phase, defined as the interval between catheter insertion and the achievement of a favorable cervix, defined as Bishop score >5.
Through study completion, an average of 1.5 years
Decreases the length from the start of the induction until full dilation
Time Frame: Through study completion, an average of 1.5 years
Length from the start of the BC insertion until fully dilation
Through study completion, an average of 1.5 years
Decreases the length from the start of the induction until the delivery
Time Frame: Through study completion, an average of 1.5 years
Length from the start of the BC insertion until the delivery
Through study completion, an average of 1.5 years
Increases the rate and the speed of spontaneous rupture of membranes (ROM) during cervical ripening
Time Frame: Through study completion, an average of 1.5 years

Spontaneous rupture of membranes (ROM) during cervical ripening or labor (Yes/No)

- If Yes, length from the insertion of the BC until spontaneous ROM.

Through study completion, an average of 1.5 years
Impacts on the rate of cesarean delivery
Time Frame: Through study completion, an average of 1.5 years
Mode of delivery (vaginal delivery vs. cesarean delivery)
Through study completion, an average of 1.5 years
Impacts on the pain and the satisfaction in women undergoing cervical ripening
Time Frame: Through study completion, an average of 1.5 years
Pain after catheter insertion assessed using a numeric rating scale (NRS, where NRS = 0 equals no pain and NRS = 10 represents the worst possible pain suffered by the participant). Participants satisfaction of the whole using a five-point Likert scale (1, very dissatisfied; 2, dissatisfied; 3, Enough Satisfied; 4, Satisfied; and 5, very satisfied)
Through study completion, an average of 1.5 years
Impacts on obstetrical and neonatal complications
Time Frame: Through study completion, an average of 1.5 years
Presence of obstetrical complications or neonatal complications
Through study completion, an average of 1.5 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 16, 2023

Primary Completion (Actual)

May 30, 2025

Study Completion (Actual)

May 30, 2025

Study Registration Dates

First Submitted

April 2, 2023

First Submitted That Met QC Criteria

May 8, 2023

First Posted (Actual)

May 18, 2023

Study Record Updates

Last Update Posted (Estimated)

June 5, 2025

Last Update Submitted That Met QC Criteria

June 2, 2025

Last Verified

June 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2022-02120

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Induction of Labor

Clinical Trials on Warm group

Subscribe